Evidence Lab

Vitamin B12

Vitamin B12 is essential for red-blood-cell formation and neurologic function. Supplementation is important when intake or absorption is inadequate, but it does not reliably improve exercise performance in people who already have adequate B12 status.

Evidence rating: Strong

Published 8/14/2026 | Last reviewed 8/14/2026

Overview

Vitamin B12, or cobalamin, is a water-soluble vitamin required for DNA synthesis, normal red-blood-cell formation and neurologic function. Deficiency can cause megaloblastic anemia, fatigue, neurologic symptoms and reduced functional capacity. Athletes following vegan or highly restrictive diets, older adults, people with pernicious anemia, gastrointestinal disease or surgery, and people using some medications may be at increased risk of low B12 status. In those settings, supplementation can be important. In contrast, available sports-nutrition evidence does not support using high-dose B12 as an energy or endurance booster when status is already adequate. B12 products contain different forms and doses, often far above the RDA because absorption becomes less efficient at high oral doses. The correct approach is to identify risk, confirm deficiency when appropriate and treat the underlying cause rather than using B12 as a generic fatigue supplement.

Common use

Preventing or correcting vitamin B12 deficiency or inadequate intake; not a general performance enhancer in B12-sufficient people.

Common forms

Cyanocobalamin and methylcobalamin tablets, capsules, lozenges and sublingual products; prescription oral or injectable forms are used in selected clinical situations.

Practical notes

Consider diet pattern, symptoms, medication use and absorption risk. Vegan diets require a reliable B12 source. Persistent fatigue, anemia or neurologic symptoms require appropriate medical assessment. Last evidence review: 14 August 2026.

Claim-level evidence

Strong

Correcting vitamin B12 deficiency can improve deficiency-related hematologic and neurologic problems.

Population: People with confirmed deficiency or high-risk inadequate intake or absorption.

Treat real deficiency; do not assume nonspecific tiredness means B12 deficiency.

Limitations: The underlying cause determines whether oral supplementation, high-dose oral therapy or injection is appropriate.

Insufficient

Vitamin B12 supplementation does not reliably improve endurance or performance in people with adequate B12 status.

Population: Healthy adults and athletes without deficiency.

Do not market B12 as an energy shot or ergogenic aid when status is sufficient.

Limitations: Sport-specific trials are limited; the main evidence based role is nutrient adequacy and deficiency treatment.

Strong

Vegans and people with impaired absorption are important B12-risk groups.

Population: Vegans, older adults and people with gastrointestinal, autoimmune or medication-related absorption risk.

Ensure a dependable B12 source and use testing or clinical care when risk is substantial.

Limitations: Risk varies with diet, fortified-food use, absorption and medical history.

Dosing context

  • General adult intake context - NIH ODS lists an RDA of 2.4 mcg/day for adults. - Any convenient time. - Ongoing nutritional intake.This is a population intake target, not a treatment dose for deficiency.
  • Deficiency treatment context - Clinical oral and injectable treatment doses can be far higher than the RDA. - According to the treatment plan. - Depends on cause and severity.Do not copy a treatment dose without diagnosis; malabsorption and neurologic symptoms may require clinician-directed therapy.

Safety notes

  • Neurologic symptoms or severe anemiaNumbness, gait change, cognitive symptoms or significant anemia can occur with B12 deficiency and require timely clinical assessment.
  • Pernicious anemia or malabsorptionPeople with intrinsic-factor deficiency, gastrointestinal surgery or significant malabsorption may require specific treatment and monitoring rather than an ordinary multivitamin dose.
  • Unnecessary megadosingB12 has no established UL, but doses far above nutritional requirements should still have a clear purpose rather than being used as a generic performance strategy.

Interactions

  • MetforminLong-term metformin use can reduce vitamin B12 status in some people; clinicians may monitor B12 in at-risk users.
  • Gastric acid inhibitorsProton-pump inhibitors and H2-receptor antagonists can reduce absorption of food-bound B12 with prolonged use.

References

  1. NIH Office of Dietary Supplements. Vitamin B12 - Health Professional Fact Sheet National Institutes of Health. 2026.Source
  2. Lukaski HC. Vitamin and mineral status: effects on physical performance Nutrition. 2004.Source